Kinshasa, Democratic Republic of the Congo — Showing early symptoms of hemorrhagic fever, the patient sits quietly on her bed, wrangling two toddlers desperate to flee the cell-like hospital room in Ingende, a remote town in the Democratic Republic of the Congo (DRC).
Vaccination centers in Europe are standing ready — but no vaccine is available. Pfizer has cut its production, and AstraZeneca has announced it would be delivering 60% less than agreed with the EU.